ADIL ALAOUI

SVP, DATA SCIENCE

 

Linkedin profile

Lucy Champ

BD DIRECTOR, REGION EU / UK

Lucy has 15+ years’ experience managing business development and marketing strategies for various multinational medical companies. Working with NHS and corporate partners, Lucy has developed, implemented and supported numerous projects focussed on pathway and service re-design to release resource and promote improved patient outcomes. An anatomist by training, Lucy graduated from The University of Liverpool in 2005 with First Class Honours in Anatomy and Human Biology. Lucy has been with eKare since the inception of their journey in the UK and Ireland.

Patrick Cheng

CEO

Patrick Cheng is Biomedical Engineer turned entrepreneur. Before starting eKare, Patrick was Technology Commercialization Officer at the Sheikh Zayed Institute (SZI) for Pediatric Surgical Innovation. Prior to that, he conducted R&D in the field of minimally invasive and image‐guide surgery. Patrick received MBA from Georgetown University, MS in Biomedical Engineering with focus on medical imaging and image analysis from the University of Iowa, and BS in Biomedical Engineering from Shanghai Jiao Tong University.

Stephen Doades

VP, REGION EU / UK

Stephen Doades is a commercial leader with 15 years global Healthcare / MedTech experience ranging from private / private equity companies to large international corporations. He has led a wide number of projects across Wearables, Medical devices and Healthtech across the US, Europe and Far East with a key focus on market access and commercialization. Previously Stephen has held commercial leadership positions for Tytex, Coloplast and Accenture. Stephen resides within Cambridge, UK.

Özgür Güler

CTO

Özgür Güler is an imaging scientist specializing in 3D wound imaging and computer vision. Prior to eKare, he was a researcher at the Sheikh Zayed Institute (SZI) for Pediatric Surgical Innovation in Washington DC, where he developed the segmentation and classification algorithms that laid the groundwork of the eKare inSight system. Dr. Güler received his PhD from the Medical University Innsbruck in Austria with focus on image‐guided diagnosis and therapy, MS in Computer Science with focus on image‐guided surgery and BS in Computer Science from Leopold‐Franzens University Innsbruck.

Brian McManus

–

As the Director of Clinical Research Operations, Brian McManus in invested in working with others to collect the cleanest data possible for clinical trials. Prior to joining the eKare team, Brian spent nearly 15 years administering research studies across the US and Europe. During this time, he also managed a wound imaging core lab for a multitude of studies with a focus of streamlining data collection processes.

Kok van der Meij

CEO OF EKARE EUROPE B.V.

Kok van der Meij was born in Leiden, The Netherlands on August 19, 1956. He describes himself as an enthusiastic communicator, marketer and sales manager with a good sense for entrepreneurship.

Kok van der Meij has founded several companies that have become successful in the Dutch market, examples include EuroTec (co-founder), Excen B.V. specialized in wound care, QualityZorg B.V. a theme home care organization in wound care.

After the sale of these companies, van der Meij is involved as a consultant in a new company in the Netherlands Wondhuis B.V. that focuses on wound concepts for regional wound centers and home care organizations that want to work with an outcome-oriented approach. Van der Meij is also involved in eKare Europe B.V. as director.

Anthony Pinto

 

Anthony Pinto is a customer success leader focused on the customer journey – from the sales process through implementation and post install success. Prior to joining eKare in 2017, Anthony spent 9 years with SigmaCare (now MatrixCare), creating and building their customer success organization that focused on both retention and growth in the EHR space. He was responsible for year over year retention rates near 98%, contributing to significant value creation and the eventual sale of the company. Anthony is a graduate of American University, with a BA in Criminal Justice.

Vincent de Waard

DIRECTOR INTERNATIONAL BUSINESS DEVELOPMENT (eKare EUROPE)

Vincent de Waard is passionate about wound care and technological applications to improve care for patients. Vincent has been working in multiple areas internationally in wound care for over 10 years. For eKare, he has been active since 2018 with activities aimed at realizing new business opportunities. Since 2020, he is also the director of Wondhuis in the Netherlands. In Europe, he combines the passion for wound care and technology at eKare, where he is responsible for International business development.

EMMANUEL WILSON

DIRECTOR, OPERATIONS

Emmanuel Wilson is a Biomedical Engineer by training with a keen focus on customer support and logistics since joining eKare in 2016. Prior to this, he was at the Sheikh Zayed Institute for Pediatric Surgical Innovation at the National Children’s Hospital as a staff scientist, where he developed and tested tools for minimally invasive surgery and computer-assisted interventions. Emmanuel received his MS in Biomedical Engineering from The Catholic University of America in Washington, D.C.

Kyle Wu

CMO

Dr. Kyle Wu is a physician entrepreneur with a special interest in medtech. Dr. Wu received surgical training at the Georgetown University Hospital. He later joined the prestigious Innovation Fellowship at the Children’s National Medical Center in Washington DC where he spearheaded the project that ultimately paved way to the founding of eKare Inc. Dr. Wu received MD/MBA degrees from Columbia University and BS in Biomedical Engineering from Johns Hopkins University. He has numerous peer‐reviewed publications in the fields of optics, imaging, and robotic surgery.

Raphael Yaakov

MS VP, CLINICAL DEVELOPMENT

Raphael’s experience spans across public health, clinical research, and technology. He has helped support key initiatives in patient education programs, global epidemiological surveillance to managing phase I-IV multinational drug and device studies. He completed his undergraduate course work in life sciences at the Pennsylvania State University and holds a MS with a concentration in pharmacoeconomics and outcomes research from University of the Sciences in Philadelphia.